±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 1021  |  »Ø¸´: 9
¡¾½±Àø¡¿ ±¾Ìû±»ÆÀ¼Û7´Î£¬×÷ÕßsoochowÔö¼Ó½ð±Ò 6.5 ¸ö
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£

soochow

ľ³æ (ÕýʽдÊÖ)


[×ÊÔ´] ¡¾×ÊÔ´¡¿¾ÛºÏÎïÖÎÁÆ¡¾ Advanced Drug Delivery Reviewsר¼­¡¿

Advanced Drug Delivery Reviews ÉÏ×îÐÂÒ»ÆÚ¹ØÓÚ¾ÛºÏÎïÓÃÓÚÖÎÁƵÄר¼­£¬Ï£Íû¸ÐÐËȤµÄÅóÓÑϲ»¶¡£
Volume 61, Issue 13,  Pages 1117-1232 (12 November 2009)
Polymer Therapeutics: Clinical Applications and Challenges for Development
Edited by M.J. Vicent and R. Duncan
http://www.sciencedirect.com/sci ... 9-999389986-1536091


¸½ÉÏһƪȫÎÄÏÂÔØ
Functional polymers as therapeutic agents: Concept to market place

http://www.namipan.com/d/ADDR%202009-61-1121%20Functional%20polymers%20as%20therapeutic%20agents-Concept%20to%20market%20place.pdf/20e03168e4a6ecc1adcdbd5364e68749375a0dfceee00600


Preface

2.         Polymer therapeutics: Clinical applications and challenges for development  Pages 1117-1120  Mar¨ªa J. Vicent, Helmut Ringsdorf, Ruth Duncan         

  Biologically Active Polymers
3.         Functional polymers as therapeutic agents: Concept to market place
Pages 1121-1130  Pradeep K. Dhal, Steven C. Polomoscanik, Louis Z. Avila, S. Randall Holmes-Farley, Robert J. Miller         

  Polymer Anticancer Conjugates
4.         Development of HPMA copolymer¨Canticancer conjugates: Clinical experience and lessons learnt  Pages 1131-1148  Ruth Duncan
         
5.         Clinical experience with anthracycline antibiotics¨CHPMA copolymer¨Chuman immunoglobulin conjugates  Pages 1149-1158 nBlanka Rihova       

6.         Design and development of polymer conjugates as anti-angiogenic agents  Pages 1159-1176  Ehud Segal, Ronit Satchi-Fainaro
         
7.         PEG conjugates in clinical development or use as anticancer agents: An overview  Pages 1177-1188  Gianfranco Pasut, Francesco M. Veronese
         
8.         Design and development of IT-101, a cyclodextrin-containing polymer conjugate of camptothecin
Pages 1189-1192
Mark E. Davis
         
9.         XMT-1001, a novel polymeric camptothecin pro-drug in clinical development for patients with advanced cancer  Pages 1193-1202  Alexander V. Yurkovetskiy, Robert J. Fram
         
10.         Combination therapy: Opportunities and challenges for polymer¨Cdrug conjugates as anticancer nanomedicines  Pages 1203-1213  Francesca Greco, Mar¨ªa J. Vicent       

11.         ProLindac™ (AP5346): A review of the development of an HPMA DACH platinum Polymer Therapeutic  Pages 1214-1219  David P Nowotnik, Esteban Cvitkovic         

  Key Issues for Transfer from Lab to Clinic
12.         Polymeric carriers: Preclinical safety and the regulatory implications for design and development of polymer therapeutics  Pages 1220-1231  Rog¨¦rio Gaspar, Ruth Duncan
»Ø¸´´ËÂ¥
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

¡ï¡ï¡ï¡ï¡ï ÎåÐǼ¶,ÓÅÐãÍÆ¼ö


ºÃ¶«¶«¡£¡£
2Â¥2009-10-21 20:07:30
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

Aill237

½ð³æ (СÓÐÃûÆø)


¡ï¡ï¡ï¡ï¡ï ÎåÐǼ¶,ÓÅÐãÍÆ¼ö

ÔÞÒ»¸ö ºÃ¶«Î÷ÊÕÏÂÁË  Ð»Ð»Â¥Ö÷
3Â¥2009-10-22 11:02:14
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

whn732

½û³æ (ÕýʽдÊÖ)


¡ï¡ï¡ï¡ï¡ï ÎåÐǼ¶,ÓÅÐãÍÆ¼ö

ѧϰÁË
4Â¥2009-10-22 17:15:19
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

chengcj.2008

ÖÁ×ðľ³æ (ÖªÃû×÷¼Ò)


¡ï¡ï¡ï¡ï¡ï ÎåÐǼ¶,ÓÅÐãÍÆ¼ö

¸ÐлÁË.
5Â¥2009-10-23 07:39:55
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

lynchpku

½ð³æ (ÕýʽдÊÖ)


¡ï¡ï¡ï ÈýÐǼ¶,Ö§³Ö¹ÄÀø

Äܲ»Äܶ¼¸ø¸öÄÉÃ×Å̰¢£¬°³ÃÇËùÂò²»Æð´óÐÍÊý¾Ý¿â°¢£¡¿´×ŸÉ׿±£¬ºÇºÇ¡£
6Â¥2009-10-23 08:16:10
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

aeskya

ľ³æ (ÕýʽдÊÖ)


¡ï¡ï¡ï¡ï¡ï ÎåÐǼ¶,ÓÅÐãÍÆ¼ö

7Â¥2009-10-23 11:58:37
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

soochow

ľ³æ (ÕýʽдÊÖ)


ллÄãµÄÈÈÐÄ
ÒýÓûØÌû:
Originally posted by aeskya at 2009-10-23 11:58:
Ó¦ls£¬´«¸öÄÉÃ×ÅÌ~

http://d.namipan.com/d/dae7aad98 ... 9b07c2f58f6519c4800

8Â¥2009-10-23 12:07:46
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

lynchpku

½ð³æ (ÕýʽдÊÖ)


ÒýÓûØÌû:
Originally posted by aeskya at 2009-10-23 11:58:
Ó¦ls£¬´«¸öÄÉÃ×ÅÌ~

http://d.namipan.com/d/dae7aad98 ... 9b07c2f58f6519c4800

߯ºÃÁË£¬¶àл¡£¹þ¹þ¡£
10Â¥2009-10-23 15:02:46
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
¼òµ¥»Ø¸´
vinci19869Â¥
2009-10-23 12:30   »Ø¸´  
 Ð»Ð»·ÖÏí£¡
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ soochow µÄÖ÷Ìâ¸üÐÂ
¡î ÎÞÐǼ¶ ¡ï Ò»ÐǼ¶ ¡ï¡ï¡ï ÈýÐǼ¶ ¡ï¡ï¡ï¡ï¡ï ÎåÐǼ¶
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] µ÷¼Á +9 JLLLLLLLLLL 2026-04-03 9/450 2026-04-04 19:20 by Öí»á·É
[¿¼ÑÐ] Çóµ÷¼Á +3 ffyyu 2026-04-02 3/150 2026-04-04 19:03 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 348Çóµ÷¼Á +4 wukira 2026-04-04 4/200 2026-04-04 18:21 by macy2011
[¿¼ÑÐ] 278Çóµ÷¼Á +9 ·¶æÃÄÈ 2026-04-04 10/500 2026-04-04 17:36 by 286640313
[¿¼ÑÐ] 283·ÖÇóµ÷¼Á +5 ÊÔÊÔ¿´ß 2026-04-04 5/250 2026-04-04 17:06 by dongzh2009
[¿¼ÑÐ] ²ÄÁÏ»¯¹¤306·ÖÕÒºÏÊʵ÷¼Á +10 ²×º£ÇáÖÛe 2026-04-04 10/500 2026-04-04 16:57 by dongzh2009
[¿¼ÑÐ] 334Çóµ÷¼Á +8 ÔøÑöÖ® 2026-04-03 8/400 2026-04-04 11:16 by w_xuqing
[¿¼ÑÐ] ±¾¿Æ211£¬293·ÖÇëÇóµ÷¼Á +6 Á«²Ë¾ÍÊÇź°É 2026-04-03 7/350 2026-04-04 11:12 by Á«²Ë¾ÍÊÇź°É
[¿¼ÑÐ] 278Çóµ÷¼Á +6 Yy7400 2026-04-03 6/300 2026-04-04 09:53 by zhangdingwa
[¿¼ÑÐ] 343Çóµ÷¼Á +8 °®î¿°í 2026-03-29 8/400 2026-04-03 22:19 by –¹Æ?
[¿¼ÑÐ] 343Çóµ÷¼Á085601 +6 ҪŬÁ¦Ñ§Ï°x 2026-03-29 7/350 2026-04-03 19:49 by °ÙÁéͯ888
[¿¼ÑÐ] ²ÄÁÏר˶µ÷¼Á +18 Ò¬Ò¬¡£ 2026-03-29 18/900 2026-04-03 16:45 by ÁáÁá0606
[¿¼ÑÐ] 11408£¬284·Ö£¬¶þÕ½Õæ³ÏÇóµ÷¼Á +4 12.27 2026-04-02 4/200 2026-04-03 14:14 by dxiaoxin
[¿¼ÑÐ] ²ÄÁϵ÷¼Á +4 Ò»ÑùYWY 2026-04-03 4/200 2026-04-03 09:48 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 298Çóµ÷¼Á +4 zzz£¬£¬r 2026-04-02 7/350 2026-04-02 18:57 by 1939136013¹·×³
[¿¼ÑÐ] Ò»Ö¾Ô¸±±¾©¿Æ¼¼´óѧ085601²ÄÁϹ¤³ÌÓ¢Ò»Êý¶þ³õÊÔ×Ü·Ö335Çóµ÷¼Á +8 Ë«ÂíβƦÀϰå2 2026-04-02 9/450 2026-04-02 14:45 by 5896
[¿¼ÑÐ] ²ÄÁϵ÷¼Á +12 Ò»ÑùYWY 2026-04-01 12/600 2026-04-02 09:15 by olim
[¿¼ÑÐ] ²ÄÁϵ÷¼Á +11 Ò»ÑùYWY 2026-03-31 11/550 2026-04-01 22:25 by zhouyuwinner
[¿¼ÑÐ] 307·ÖÇóµ÷¼Á +14 (o~o) 2026-03-31 15/750 2026-04-01 20:43 by longlotian
[¿¼ÑÐ] 085601Ó¢¶þÊý¶þÇóµ÷¼Á ×Ü·Ö325 +4 Óຽº½ 2026-03-31 4/200 2026-03-31 17:38 by ÌÆãå¶ù
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û